-
Founded in:
2012-09-21 -
Country:
China -
Address:
No. 8, Section 2, Taipei Road, Guanghan City, Deyang City, Sichuan Province -
Tax NO.:
91510681054120040U -
Registered Funds:
30 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Fexofenadine hydrochloride |
No specific description provided
More
No specific description provided |
153439-40-8 | 48 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cilostazol |
It inhibits the activity of phosphodiesterase in platelets and vascular smooth muscle, increases the concentration of cAMP in platelets and smooth muscle, and exerts antiplatelet and vasodilator effects. It inhibits the initial and secondary aggregation and release reactions of platelets induced by ADP, adrenaline, collagen and arachidonic acid, and is dose-dependent. It does not interfere with the synthesis of vascular protective prostacyclin by endothelial cells, and can increase tissue blood flow in the foot and gastrocnemius muscle, increase the blood pressure index of the lower limbs, increase skin blood flow and skin temperature of the limbs, and improve intermittent claudication.
More
It inhibits the activity of phosphodiesterase in platelets and vascular smooth muscle, increases the concentration of cAMP in platelets and smooth muscle, and exerts antiplatelet and vasodilator effects. It inhibits the initial and secondary aggregation and release reactions of platelets induced by ADP, adrenaline, collagen and arachidonic acid, and is dose-dependent. It does not interfere with the synthesis of vascular protective prostacyclin by endothelial cells, and can increase tissue blood flow in the foot and gastrocnemius muscle, increase the blood pressure index of the lower limbs, increase skin blood flow and skin temperature of the limbs, and improve intermittent claudication. |
73963-72-1 | 30 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cilostazol |
This product and its metabolites are cyclic adenosine monophosphate (cAMP) phosphodiesterase III inhibitors (PDEIII inhibitors), which can reduce the degradation of cAMP by inhibiting the activity of phosphodiesterase, thereby increasing the cAMP level in platelets and blood vessels, inhibiting platelet aggregation and vasodilation.
More
This product and its metabolites are cyclic adenosine monophosphate (cAMP) phosphodiesterase III inhibitors (PDEIII inhibitors), which can reduce the degradation of cAMP by inhibiting the activity of phosphodiesterase, thereby increasing the cAMP level in platelets and blood vessels, inhibiting platelet aggregation and vasodilation. |
73963-72-1 | 30 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cilostazol |
This product and its metabolites are cyclic adenosine monophosphate (cAMP) phosphodiesterase III inhibitors (PDEIII inhibitors), which can reduce the degradation of cAMP by inhibiting the activity of phosphodiesterase, thereby increasing the cAMP level in platelets and blood vessels, inhibiting platelet aggregation and vasodilation.
More
This product and its metabolites are cyclic adenosine monophosphate (cAMP) phosphodiesterase III inhibitors (PDEIII inhibitors), which can reduce the degradation of cAMP by inhibiting the activity of phosphodiesterase, thereby increasing the cAMP level in platelets and blood vessels, inhibiting platelet aggregation and vasodilation. |
73963-72-1 | 30 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Amlexanox |
No specific description provided
More
No specific description provided |
68302-57-8 | 4 |